5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T35528 | TD52 | Apoptosis , Phosphatase , Akt | |
TD52 is an orally active inhibitor of cancerous inhibitor of PP2A (CIP2A). TD52 is an Erlotinib derivative and indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. | |||
T35528L | TD52 dihydrochloride | TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl | Others |
TD52 dihydrochloride (TD52 2HCl), a derivative of Erlotinib, is a potent and orally active inhibitor of protein phosphatase 2A (CIP2A). It exhibits strong anti-cancer properties by regulating the CIP2A/PP2A/p-Akt signali... | |||
T72956 | Darizmetinib | HRX215 | MAPK |
Darizmetinib (HRX215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and li... | |||
TP2157 | TAT-DEF-Elk-1 | TDE | Others |
TAT-DEF-Elk-1 is a cell-penetrating peptide Elk-1 inhibitor. | |||
TP2157L | TAT-DEF-Elk-1 TFA (1220751-16-5 free base) | TDE TFA,TAT-DEF-Elk-1 TFA | Others |
TAT-DEF-Elk-1 TFA is a cell-penetrating peptide Elk-1 inhibitor, mimics and specifically interferes with the DEF domain of Elk-1. TAT-DEF-Elk-1 blocks Elk-1 phosphorylation and prevents Elk-1 nuclear translocation withou... |